Results

Total Results: 1,070 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. hcup-us.ahrq.gov/reports/methods/2010_03.pdf
    January 01, 2010 - of head and neck 32 (3) 29 (3) 7.67 (0.19) 6.221 (c) 3.77 (0.39) 6.591 (c) 12: Cancer of … of rectum and anus 47 (2) 37* (3) 8.58 (0.11) 7.881 (c) 3.08 (0.21) 3.571 (c) 16: Cancer … of uterus 41 (2) 30* (3) 4.19 (0.10) 4.151 (c) 1.26 (0.14) 1.351 (c) 26: Cancer of cervix … 23 (1) 20 (2) 3.55 (0.09) 3.661 (c) 1.60 (0.18) 0.791 (c) 27: Cancer of ovary 25 (1) 25 (3) … 6.76 (0.15) 6.001 (c) 4.48 (0.38) 3.971 (c) 30: Cancer of testis 2 (0) --1 (a) 6.31 (0.39)
  2. hcup-us.ahrq.gov/reports/statbriefs/sb118.pdf
    August 01, 2011 - Injuries (including poisonings, multiple trauma, and burns) and neoplasms each accounted for about 2 … (KID), 2009 46 50 61 63 79 89 93 128 138 139 144 155 172 266 510 0 100 200 300 400 500 600 NeoplasmsCancer chemotherapy and artificial rupture of membranes to assist in delivery were ranked eighth and … Cancer chemotherapy 47,900 64.3 9. … HCUP data include OB-GYN, ENT, orthopedic, cancer, pediatric, public, and academic medical hospitals
  3. hcup-us.ahrq.gov/toolssoftware/comorbidity/comoanaly_01.txt
    December 08, 2004 - DM DMCX HYPOTHY RENLFAIL LIVER ULCER AIDS LYMPH METS TUMOR … **********************************************/ IF HTNCX = 1 THEN HTN = 0 ; IF METS = 1 THEN TUMOR … AND CANCFLG THEN TUMOR = 0; IF ARTH AND ARTHFLG THEN ARTH = 0; IF COAG AND DRG = 397 THEN COAG … immune deficiency syndrome' LYMPH = 'Lymphoma' METS = 'Metastatic cancer … ' TUMOR = 'Solid tumor w/out metastasis' ARTH = 'Rheumatoid arthritis
  4. hcup-us.ahrq.gov/reports/race/C18RECaseStudyReportforWEBfinal99.pdf
    January 01, 2020 - http://www.cdc.gov/asthma/pdfs/asthma_guide.pdf and Division of Cancer Prevention and Control, Centers … http://www.cdc.gov/cancer/ncccp/pdf/Guidance-Guidelines.pdf NH MA ME NJ CT RI DE VT NY DC … Cancer organizations in the state are particularly interested in race/ethnicity data. … DHS found that hospitalization rates for certain cancers are very high among Hmong populations in other … DHS programs, the Wisconsin Cancer Reporting System and the Wisconsin Comprehensive Cancer Control Program
  5. hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2025-1.pdf
    November 01, 2024 - • Removed C80.1, Malignant (primary) neoplasm, unspecified, and R180, Malignant ascites, as these … are not indicative of metastatic cancer. … • Focused this measure on solid malignant tumors without metastasis, starting with v2021.1. … • Added diagnosis codes that align with the National Cancer Institute’s classification of cancer … Additionally, added diagnosis codes indicative of cancers of the skin.
  6. hcup-us.ahrq.gov/toolssoftware/comorbidity/comoanaly_2003.txt
    January 01, 2003 - DM DMCX HYPOTHY RENLFAIL LIVER ULCER AIDS LYMPH METS TUMOR … **********************************************/ IF HTNCX = 1 THEN HTN = 0 ; IF METS = 1 THEN TUMOR … AND CANCFLG THEN TUMOR = 0; IF ARTH AND ARTHFLG THEN ARTH = 0; IF COAG AND DRG = 397 THEN COAG … immune deficiency syndrome' LYMPH = 'Lymphoma' METS = 'Metastatic cancer … ' TUMOR = 'Solid tumor w/out metastasis' ARTH = 'Rheumatoid arthritis
  7. hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2008_Severity.TXT
    January 01, 2008 - Severity 27 CM_METS 97 98 Num AHRQ comorbidity measure: Metastatic cancer … 2008 Severity 35 CM_TUMOR 113 114 Num AHRQ comorbidity measure: Solid tumor
  8. hcup-us.ahrq.gov/db/nation/nis/tools/stats/FileSpecifications_NIS_2009_Severity.TXT
    January 01, 2009 - Severity 27 CM_METS 97 98 Num AHRQ comorbidity measure: Metastatic cancer … 2009 Severity 35 CM_TUMOR 113 114 Num AHRQ comorbidity measure: Solid tumor
  9. hcup-us.ahrq.gov/db/nation/kid/tools/stats/FileSpecifications_KID_2009_Severity.TXT
    January 01, 2009 - Severity 27 CM_METS 91 92 Num AHRQ comorbidity measure: Metastatic cancer … 2009 Severity 35 CM_TUMOR 107 108 Num AHRQ comorbidity measure: Solid tumor
  10. hcup-us.ahrq.gov/toolssoftware/comorbidityicd10/CMR-User-Guide-v2024-1.pdf
    December 01, 2023 - • Removed C80.1, Malignant (primary) neoplasm, unspecified, and R180, Malignant ascites, as these … are not indicative of metastatic cancer. … • Focused this measure on solid malignant tumors without metastasis, starting with v2021.1. … • Added diagnosis codes that align with the National Cancer Institute’s classification of cancer … Additionally, added diagnosis codes indicative of cancers of the skin.
  11. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2010_MaskedStats_Severity_V2.PDF
    January 01, 2010 - electrolyte disorders 13,907,610 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,907,610 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,922 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,995 0.14% 692: Radiotherapy 1,534 0.01% 693: Chemotherapy 61,552 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,680 0.09% 710: Infectious & parasitic diseases including HIV w
  12. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2012_MaskedStats_Severity_V2.PDF
    January 01, 2012 - electrolyte disorders 13,459,216 0 0.00 1.00 0.21 0.41 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,459,216 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,811 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 7,576 0.06% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 9,897 0.07% 690 … 18,144 0.13% 692: Radiotherapy 1,115 0.01% 693: Chemotherapy 58,907 0.44% 694: Lymphatic & other malignancies
  13. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2013_MaskedStats_Severity.PDF
    January 01, 2013 - electrolyte disorders 14,325,172 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 14,325,172 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 11,987 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … Percent of Total 692: Radiotherapy 1,114 0.01% 693: Chemotherapy 62,706 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,072 0.08% 710: Infectious & parasitic diseases including HIV w
  14. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2011_MaskedStats_V2_Severity.PDF
    January 01, 2011 - electrolyte disorders 13,915,176 0 0.00 1.00 0.21 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 13,915,176 0 0.00 1.00 0.10 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 12,699 0.09% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 18,617 0.13% 692: Radiotherapy 1,207 0.01% 693: Chemotherapy 61,609 0.44% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 12,416 0.09% 710: Infectious & parasitic diseases including HIV w
  15. hcup-us.ahrq.gov/news/newsletters/newsltrQ1_2016.html
    January 01, 2016 - The Statistical Brief found that while breast cancer rates have remained constant, the rate of women … Laparoscopic and robot-assisted hysterectomy for uterine cancer: a comparison of costs and complications … the costs and complications among women who undergo robotic and laparoscopic hysterectomy for uterine cancer
  16. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2011_MaskedStats_Severity.PDF
    January 01, 2011 - electrolyte disorders 8,023,590 0 0.00 1.00 0.20 0.40 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 8,023,590 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 6,517 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,946 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 5,098 0.06% 690 … & neoplasms of uncertain behavior 6,509 0.08% 710: Infectious & parasitic diseases including HIV w
  17. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Severity.PDF
    January 01, 2012 - electrolyte disorders 3,195,782 0 0.00 1.00 0.08 0.27 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 3,195,782 0 0.00 1.00 0.00 0.06 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 4,907 0.15% 110: Ear, nose, mouth, throat, cranial/facial malignancies … for APRDRG APRDRG Frequency Percent of Total 693: Chemotherapy 32,305 1.01% 694: Lymphatic & other malignancies … & neoplasms of uncertain behavior 475 0.01% 710: Infectious & parasitic diseases including HIV w O.R
  18. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2014_MaskedStats_Severity.PDF
    January 01, 2014 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,071,762 0 0.00 1.00 0.11 0.31 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,370 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,499 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,365 0.06% 690 … Percent of Total 692: Radiotherapy 586 0.01% 693: Chemotherapy 29,695 0.42% 694: Lymphatic & other malignancies
  19. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2013_MaskedStats_Severity.PDF
    January 01, 2013 - Variable / Label N N Miss Minimum Maximum Mean Std Dev CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 7,119,563 0 0.00 1.00 0.10 0.30 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 5,780 0.08% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 3,581 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 4,512 0.06% 690 … Percent of Total 692: Radiotherapy 664 0.01% 693: Chemotherapy 30,425 0.43% 694: Lymphatic & other malignancies
  20. hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2015Q1Q3_Severity.PDF
    November 08, 2017 - electrolyte disorders 5,377,720 0 0.00 1.00 0.22 0.42 CM_METS : AHRQ comorbidity measure: Metastatic cancer … measure: Renal failure 5,377,720 0 0.00 1.00 0.11 0.32 CM_TUMOR : AHRQ comorbidity measure: Solid tumor … Other ear, nose, mouth & throat procedures 3,979 0.07% 110: Ear, nose, mouth, throat, cranial/facial malignancies … 2,580 0.05% 681: Other O.R. procedures for lymphatic/hematopoietic/other neoplasms 3,152 0.06% 690 … & neoplasms of uncertain behavior 3,745 0.07% 710: Infectious & parasitic diseases including HIV w

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: